Exane Derivatives Masimo Corp Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Masimo Corp stock. As of the latest transaction made, Exane Derivatives holds 2 shares of MASI stock, worth $336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$336
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MASI
# of Institutions
394Shares Held
43MCall Options Held
310KPut Options Held
268K-
Black Rock Inc. New York, NY9.35MShares$1.57 Billion0.03% of portfolio
-
Politan Capital Management LP New York, NY4.71MShares$794 Million35.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$761 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$257 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY1.46MShares$246 Million3.11% of portfolio
About MASIMO CORP
- Ticker MASI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 52,530,200
- Market Cap $8.84B
- Description
- Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...